In the long term, Eqos’s current stature and means may not be enough to maintain its competitive position against current and potential competitors, especially those with significantly greater financial resources, name recognition, and other resources.
bi consulting for pharmaceutical
financial settlements, supplier scorecards, bid comparisons, and so on, is only one part of the entire process. But what about the other accompanying processes involved with compliance and testing partners, local and international third party logistics (3PLs), customs, financial institutions, distribution centers (DCs), individual stores, and so on? Accommodating and enabling freight forwarders, non-vessel operating common carriers (NVOCCs), consolidators, customs house brokers, export management